Paul Chapman on a hookworm vaccine
The Lancet Infectious Diseases in conversation with - A podcast by The Lancet Group
![](https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/89/d6/59/89d659f6-842b-f713-172e-276b137a7250/mza_13591906078518338376.jpg/300x300bb-75.jpg)
Categories:
Paul Chapman and colleagues presents the results of an innovative trial assessing the safety of vaccinating healthy volunteers with attenuated Necator americanus hookworm larvae. Read the full article:https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00153-5/fulltextContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv